Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2003 Dec 1;49(12):1989–1996. doi: 10.1373/clinchem.2003.023184

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2003 The American Association for Clinical Chemistry

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 1. — Comparison of the detection rates of 41 synthesized peptides spanning different sequences of the SARS-coronavirus structural proteins.

Shown are peptides from SARS-coronavirus structural proteins S (panel A), M (panel B), and N (panel C). The x/31 axis represents the percentage of immunoreactivity of the synthesized peptide screened by sera from 31 SARS patients.